ARCOSA INC (ACA) Stock Fundamental Analysis

USA • New York Stock Exchange • NYSE:ACA • US0396531008

124.74 USD
+3.91 (+3.24%)
At close: Feb 6, 2026
124.74 USD
0 (0%)
After Hours: 2/6/2026, 8:16:39 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

5

Taking everything into account, ACA scores 5 out of 10 in our fundamental rating. ACA was compared to 55 industry peers in the Construction & Engineering industry. ACA has only an average score on both its financial health and profitability. ACA has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

  • In the past year ACA was profitable.
  • In the past year ACA had a positive cash flow from operations.
  • ACA had positive earnings in each of the past 5 years.
  • Each year in the past 5 years ACA had a positive operating cash flow.
ACA Yearly Net Income VS EBIT VS OCF VS FCFACA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M

1.2 Ratios

  • ACA has a Return On Assets (2.94%) which is in line with its industry peers.
  • Looking at the Return On Equity, with a value of 5.75%, ACA is in line with its industry, outperforming 41.82% of the companies in the same industry.
  • Looking at the Return On Invested Capital, with a value of 4.99%, ACA is in line with its industry, outperforming 47.27% of the companies in the same industry.
  • Measured over the past 3 years, the Average Return On Invested Capital for ACA is significantly below the industry average of 15.84%.
  • The last Return On Invested Capital (4.99%) for ACA is above the 3 year average (3.99%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 2.94%
ROE 5.75%
ROIC 4.99%
ROA(3y)4.56%
ROA(5y)3.97%
ROE(3y)7.3%
ROE(5y)6.21%
ROIC(3y)3.99%
ROIC(5y)4.04%
ACA Yearly ROA, ROE, ROICACA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2 4 6 8 10

1.3 Margins

  • With a decent Profit Margin value of 5.25%, ACA is doing good in the industry, outperforming 63.64% of the companies in the same industry.
  • ACA's Profit Margin has declined in the last couple of years.
  • Looking at the Operating Margin, with a value of 10.27%, ACA is in the better half of the industry, outperforming 72.73% of the companies in the same industry.
  • ACA's Operating Margin has declined in the last couple of years.
  • Looking at the Gross Margin, with a value of 21.61%, ACA is in the better half of the industry, outperforming 65.45% of the companies in the same industry.
  • ACA's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 10.27%
PM (TTM) 5.25%
GM 21.61%
OM growth 3Y11.96%
OM growth 5Y-2.91%
PM growth 3Y2.37%
PM growth 5Y-10.81%
GM growth 3Y3.69%
GM growth 5Y0.93%
ACA Yearly Profit, Operating, Gross MarginsACA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15 20

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

5

2. Health

2.1 Basic Checks

  • ACA has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
  • The number of shares outstanding for ACA has been increased compared to 1 year ago.
  • Compared to 5 years ago, ACA has more shares outstanding
  • Compared to 1 year ago, ACA has a worse debt to assets ratio.
ACA Yearly Shares OutstandingACA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M
ACA Yearly Total Debt VS Total AssetsACA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B

2.2 Solvency

  • An Altman-Z score of 2.63 indicates that ACA is not a great score, but indicates only limited risk for bankruptcy at the moment.
  • The Altman-Z score of ACA (2.63) is comparable to the rest of the industry.
  • ACA has a debt to FCF ratio of 5.03. This is a neutral value as ACA would need 5.03 years to pay back of all of its debts.
  • ACA's Debt to FCF ratio of 5.03 is fine compared to the rest of the industry. ACA outperforms 63.64% of its industry peers.
  • A Debt/Equity ratio of 0.61 indicates that ACA is somewhat dependend on debt financing.
  • The Debt to Equity ratio of ACA (0.61) is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.61
Debt/FCF 5.03
Altman-Z 2.63
ROIC/WACC0.52
WACC9.54%
ACA Yearly LT Debt VS Equity VS FCFACA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B

2.3 Liquidity

  • A Current Ratio of 2.02 indicates that ACA has no problem at all paying its short term obligations.
  • The Current ratio of ACA (2.02) is better than 87.27% of its industry peers.
  • A Quick Ratio of 1.30 indicates that ACA should not have too much problems paying its short term obligations.
  • With a Quick ratio value of 1.30, ACA perfoms like the industry average, outperforming 56.36% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.02
Quick Ratio 1.3
ACA Yearly Current Assets VS Current LiabilitesACA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

6

3. Growth

3.1 Past

  • ACA shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 17.03%, which is quite good.
  • Measured over the past 5 years, ACA shows a small growth in Earnings Per Share. The EPS has been growing by 5.16% on average per year.
  • The Revenue has grown by 13.96% in the past year. This is quite good.
  • The Revenue has been growing by 8.15% on average over the past years. This is quite good.
EPS 1Y (TTM)17.03%
EPS 3Y16.17%
EPS 5Y5.16%
EPS Q2Q%71.43%
Revenue 1Y (TTM)13.96%
Revenue growth 3Y8.06%
Revenue growth 5Y8.15%
Sales Q2Q%24.58%

3.2 Future

  • ACA is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 21.76% yearly.
  • The Revenue is expected to grow by 7.15% on average over the next years.
EPS Next Y41.62%
EPS Next 2Y26.58%
EPS Next 3Y21.76%
EPS Next 5YN/A
Revenue Next Year10.81%
Revenue Next 2Y8.17%
Revenue Next 3Y7.15%
Revenue Next 5YN/A

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
ACA Yearly Revenue VS EstimatesACA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 1B 2B 3B
ACA Yearly EPS VS EstimatesACA Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 1 2 3 4 5

More info and screens

Find the best growth stocksShow best growing peers

5

4. Valuation

4.1 Price/Earnings Ratio

  • The Price/Earnings ratio is 33.00, which means the current valuation is very expensive for ACA.
  • ACA's Price/Earnings ratio is a bit cheaper when compared to the industry. ACA is cheaper than 61.82% of the companies in the same industry.
  • ACA is valuated at similar levels of the S&P average when we compare the Price/Earnings ratio to 27.93, which is the current average of the S&P500 Index.
  • A Price/Forward Earnings ratio of 25.86 indicates a quite expensive valuation of ACA.
  • Based on the Price/Forward Earnings ratio, ACA is valued a bit cheaper than 74.55% of the companies in the same industry.
  • ACA is valuated at similar levels of the S&P average when we compare the Price/Forward Earnings ratio to 27.77, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 33
Fwd PE 25.86
ACA Price Earnings VS Forward Price EarningsACA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of ACA indicates a rather cheap valuation: ACA is cheaper than 81.82% of the companies listed in the same industry.
  • Based on the Price/Free Cash Flow ratio, ACA is valued a bit cheaper than the industry average as 80.00% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 19.45
EV/EBITDA 14.47
ACA Per share dataACA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30 40 50

4.3 Compensation for Growth

  • ACA's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • ACA's earnings are expected to grow with 21.76% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.79
PEG (5Y)6.39
EPS Next 2Y26.58%
EPS Next 3Y21.76%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

4

5. Dividend

5.1 Amount

  • With a yearly dividend of 0.17%, ACA is not a good candidate for dividend investing.
  • Compared to an average industry Dividend Yield of 0.14, ACA pays a bit more dividend than its industry peers.
  • With a Dividend Yield of 0.17, ACA pays less dividend than the S&P500 average, which is at 1.81.
Industry RankSector Rank
Dividend Yield 0.17%

5.2 History

  • The dividend of ACA decreases each year by -0.48%.
  • ACA has been paying a dividend for over 5 years, so it has already some track record.
  • ACA has not decreased its dividend in the past 5 years, so it has a somewhat stable track record.
Dividend Growth(5Y)-0.48%
Div Incr Years0
Div Non Decr Years5
ACA Yearly Dividends per shareACA Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 2025 2026 0.05 0.1 0.15

5.3 Sustainability

  • 6.66% of the earnings are spent on dividend by ACA. This is a low number and sustainable payout ratio.
DP6.66%
EPS Next 2Y26.58%
EPS Next 3Y21.76%
ACA Yearly Income VS Free CF VS DividendACA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M
ACA Dividend Payout.ACA Dividend Payout, showing the Payout Ratio.ACA Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

ARCOSA INC

NYSE:ACA (2/6/2026, 8:16:39 PM)

After market: 124.74 0 (0%)

124.74

+3.91 (+3.24%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryConstruction & Engineering
Earnings (Last)10-30
Earnings (Next)02-26
Inst Owners94.81%
Inst Owner Change-2.77%
Ins Owners1.8%
Ins Owner Change-1.18%
Market Cap6.12B
Revenue(TTM)2.83B
Net Income(TTM)148.60M
Analysts86
Price Target126.28 (1.23%)
Short Float %1.85%
Short Ratio4.11
Dividend
Industry RankSector Rank
Dividend Yield 0.17%
Yearly Dividend0.2
Dividend Growth(5Y)-0.48%
DP6.66%
Div Incr Years0
Div Non Decr Years5
Ex-Date01-15
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)16.63%
Min EPS beat(2)15.61%
Max EPS beat(2)17.65%
EPS beat(4)3
Avg EPS beat(4)38.79%
Min EPS beat(4)-40.32%
Max EPS beat(4)162.24%
EPS beat(8)7
Avg EPS beat(8)30.62%
EPS beat(12)11
Avg EPS beat(12)32.12%
EPS beat(16)15
Avg EPS beat(16)40.53%
Revenue beat(2)1
Avg Revenue beat(2)-1.27%
Min Revenue beat(2)-3.72%
Max Revenue beat(2)1.18%
Revenue beat(4)2
Avg Revenue beat(4)-1.29%
Min Revenue beat(4)-4.44%
Max Revenue beat(4)1.83%
Revenue beat(8)4
Avg Revenue beat(8)-0.83%
Revenue beat(12)7
Avg Revenue beat(12)0.53%
Revenue beat(16)11
Avg Revenue beat(16)1.99%
PT rev (1m)3.34%
PT rev (3m)6.72%
EPS NQ rev (1m)-0.56%
EPS NQ rev (3m)1.71%
EPS NY rev (1m)0.29%
EPS NY rev (3m)4.09%
Revenue NQ rev (1m)-0.46%
Revenue NQ rev (3m)-0.46%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.17%
Valuation
Industry RankSector Rank
PE 33
Fwd PE 25.86
P/S 2.16
P/FCF 19.45
P/OCF 13.04
P/B 2.37
P/tB 6.66
EV/EBITDA 14.47
EPS(TTM)3.78
EY3.03%
EPS(NY)4.82
Fwd EY3.87%
FCF(TTM)6.41
FCFY5.14%
OCF(TTM)9.57
OCFY7.67%
SpS57.76
BVpS52.7
TBVpS18.72
PEG (NY)0.79
PEG (5Y)6.39
Graham Number66.95
Profitability
Industry RankSector Rank
ROA 2.94%
ROE 5.75%
ROCE 6.5%
ROIC 4.99%
ROICexc 5.24%
ROICexgc 8.62%
OM 10.27%
PM (TTM) 5.25%
GM 21.61%
FCFM 11.11%
ROA(3y)4.56%
ROA(5y)3.97%
ROE(3y)7.3%
ROE(5y)6.21%
ROIC(3y)3.99%
ROIC(5y)4.04%
ROICexc(3y)4.17%
ROICexc(5y)4.21%
ROICexgc(3y)7.17%
ROICexgc(5y)7.33%
ROCE(3y)5.21%
ROCE(5y)5.27%
ROICexgc growth 3Y4.01%
ROICexgc growth 5Y-10.09%
ROICexc growth 3Y4.98%
ROICexc growth 5Y-11.63%
OM growth 3Y11.96%
OM growth 5Y-2.91%
PM growth 3Y2.37%
PM growth 5Y-10.81%
GM growth 3Y3.69%
GM growth 5Y0.93%
F-Score5
Asset Turnover0.56
Health
Industry RankSector Rank
Debt/Equity 0.61
Debt/FCF 5.03
Debt/EBITDA 3.04
Cap/Depr 68.36%
Cap/Sales 5.46%
Interest Coverage 250
Cash Conversion 90.74%
Profit Quality 211.71%
Current Ratio 2.02
Quick Ratio 1.3
Altman-Z 2.63
F-Score5
WACC9.54%
ROIC/WACC0.52
Cap/Depr(3y)104.81%
Cap/Depr(5y)89.02%
Cap/Sales(3y)7.45%
Cap/Sales(5y)6.15%
Profit Quality(3y)128.08%
Profit Quality(5y)133.99%
High Growth Momentum
Growth
EPS 1Y (TTM)17.03%
EPS 3Y16.17%
EPS 5Y5.16%
EPS Q2Q%71.43%
EPS Next Y41.62%
EPS Next 2Y26.58%
EPS Next 3Y21.76%
EPS Next 5YN/A
Revenue 1Y (TTM)13.96%
Revenue growth 3Y8.06%
Revenue growth 5Y8.15%
Sales Q2Q%24.58%
Revenue Next Year10.81%
Revenue Next 2Y8.17%
Revenue Next 3Y7.15%
Revenue Next 5YN/A
EBIT growth 1Y48.65%
EBIT growth 3Y20.99%
EBIT growth 5Y5.01%
EBIT Next Year135.94%
EBIT Next 3Y39.06%
EBIT Next 5YN/A
FCF growth 1Y5015.62%
FCF growth 3Y56.55%
FCF growth 5Y2.7%
OCF growth 1Y146.35%
OCF growth 3Y44.47%
OCF growth 5Y6.95%

ARCOSA INC / ACA FAQ

Can you provide the ChartMill fundamental rating for ARCOSA INC?

ChartMill assigns a fundamental rating of 5 / 10 to ACA.


Can you provide the valuation status for ARCOSA INC?

ChartMill assigns a valuation rating of 5 / 10 to ARCOSA INC (ACA). This can be considered as Fairly Valued.


How profitable is ARCOSA INC (ACA) stock?

ARCOSA INC (ACA) has a profitability rating of 5 / 10.


What is the valuation of ARCOSA INC based on its PE and PB ratios?

The Price/Earnings (PE) ratio for ARCOSA INC (ACA) is 33 and the Price/Book (PB) ratio is 2.37.


How financially healthy is ARCOSA INC?

The financial health rating of ARCOSA INC (ACA) is 5 / 10.